Exhibit 99.2
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13G filed
herewith (and any amendments thereto), relating to the Common Stock of NPS
Pharmaceuticals, Inc., a Delaware corporation, is being filed jointly with
the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the
Securities Exchange Act of 1934, as amended, on behalf of each of the
undersigned.
This Agreement may be executed in counterparts and each of such
counterparts taken together shall constitute one and the same instrument.
Dated this 28th day of March, 2013.
TAKEDA PHARMACEUTICAL COMPANY LIMITED
By: /s/ Toshinobu Mamiya
--------------------------
Name: Toshinobu Mamiya
Title: Senior Director, Corporate Treasury
TAKEDA PHARMA A/S
By: /s/ Xxxxxx Xxxxxxx
--------------------------
Name: Xxxxxx Xxxxxxx
Title: Area Head, N.W. Europe & Canada
TAKEDA GMBH
By: X. Xxxxxxxx
--------------------------
Name: Xxxxxx Xxxxxxxx
Title: Vice President
By: Xxxxxxxxx Xxxxxxxx
--------------------------
Name: Xxxxxxxxx Xxxxxxxx
Title: Senior Director
